Chirality is a key factor for the safety and efficacy of many drug products, and thus the production of single enantiomers of drug intermediates has become increasingly important in the pharmaceutical industry. There has been an enormous potential of microorganisms and enzymes derived therefrom for the transformation of synthetic chemicals with high chemo‐, regio‐, and enatioselectivities. In this article, chemoenzymatic processes, are described, for the synthesis of chiral intermediates for development of pharmaceuticals.